FDA Inspection 1204464 — OMNILIFE USA, Inc. dba Texas OMNILIFE USA, Inc.
The FDA completed an inspection of OMNILIFE USA, Inc. dba Texas OMNILIFE USA, Inc. on April 28, 2023 in San Jose, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Food/Cosmetics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- April 28, 2023
- Fiscal Year
- 2023
- Product Type
- Food/Cosmetics
- Project Area
- Food Composition, Standards, Labeling and Econ
- Location
- San Jose, CA (United States)